Human Mesotrypsin Defies Natural Trypsin Inhibitors: From Passive Resistance to Active Destruction.

Author(s): Miklos Sahin-Toth.

Journal Name: Protein & Peptide Letters

Volume 12 , Issue 5 , 2005

Become EABM
Become Reviewer

Abstract:

More than twenty years ago Rinderknecht et al. identified a minor trypsin isoform resistant to natural trypsin inhibitors in the human pancreatic juice. At the same time, Estell and Laskowski found that an inhibitor-resistant trypsin from the pyloric caeca of the starfish, Dermasterias imbricata rapidly hydrolyzed the reactive-site peptide bonds of trypsin inhibitors. A connection between these two seminal discoveries was made recently, when human mesotrypsin was shown to cleave the reactive-site peptide bond of the Kunitz-type soybean trypsin inhibitor, and degrade the Kazal-type pancreatic secretory trypsin inhibitor. These observations indicate that proteases specialized for the degradation of protease inhibitors are ubiquitous in metazoa, and prompt new investigations into their biological significance. Here we review the history and properties of human mesotrypsin, and discuss its function in the digestive degradation of dietary trypsin inhibitors and possible pathophysiological role in pancreatitis.

Keywords: trypsinogen, proteomics, t cell receptor genes, mesotrypsin, polypeptide inhibitors, enteropeptidase, duodenum

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 12
ISSUE: 5
Year: 2005
Page: [457 - 464]
Pages: 8
DOI: 10.2174/0929866054395356
Price: $65

Article Metrics

PDF: 1